Nexus Investment Management Ulc Tekla Life Sciences Investors Transaction History
Nexus Investment Management Ulc
- $601 Million
- Q1 2025
A detailed history of Nexus Investment Management Ulc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Nexus Investment Management Ulc holds 1,489 shares of HQL stock, worth $19,371. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,489Holding current value
$19,371% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
85Shares Held
9.55MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$44.6 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.72 Million0.17% of portfolio
-
Karpus Management, Inc. Pittsford, NY490KShares$6.37 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.43 Million0.12% of portfolio
-
Morgan Stanley New York, NY366KShares$4.76 Million0.0% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...